Publications by authors named "F C Sherman"

Claim this Profile
D
Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945.
Yueyang Wang, Yuan Hao, Michela Ranieri, Tigran M Abramyan, Lev Tsidilkovski, Fiona Sherman

NPJ Precis Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models.
Dezhi Li, Ke Geng, Yuan Hao, Jiajia Gu, Saurav Kumar, Fiona Sherman

J Clin Invest· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer.
Xinyuan Tong, Ayushi S Patel, Eejung Kim, Hongjun Li, Yueqing Chen, Fiona Sherman

Cancer Cell· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression.
Atsushi Okato, Takanobu Utsumi, Michela Ranieri, Xingnan Zheng, Mi Zhou, Fiona Sherman

J Clin Invest· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy.
Suman Mukhopadhyay, Hsin-Yi Huang, Ziyan Lin, Michela Ranieri, Shuai Li, Fiona Sherman

Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis